Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 11:12 AM ET


Company Overview of E. Merck KG

Company Overview

E. Merck KG operates as a general partner for Merck KGaA, which develops, manufactures, and distributes pharmaceutical products. The company is based in Darmstadt, Germany.

Frankfurter Strasse 250

Darmstadt,  64293


Key Executives for E. Merck KG

Chairman of the Executive Board of Merck KGaA and Chief Executive Officer at Merck KGaA
Age: 58
Member of executive Board
Age: 64
Compensation as of Fiscal Year 2015.

E. Merck KG Key Developments

E. Merck KG Announces Management Changes, Effective January 1, 2015

Merck KGaA announced E. Merck KG has appointed Stefan Oschmann to the position of Vice Chairman and Deputy CEO. Concurrently, Bel n Garijo has been appointed to the Executive Board to take over leadership for the Pharma business. The management changes will be effective as of January 1, 2015. Oschmann, currently CEO Pharma, will represent Karl-Ludwig Kley, Chief Executive Officer and Chairman of the Executive Board, in hisresponsibilities. Both will share strategic management functions and represent the company with politicians and international organizations. As a member of the Executive Board, Garijo, currently CEO of Merck's biopharmaceutical division Merck Serono, will assume responsibility for the whole Pharma business, which in addition to Merck Serono comprisesConsumer Health, Allergy and Biosimilars.

E. Merck KG Announces Board Changes

E. Merck KG has appointed Frank Stangenberg-Haverkamp as the new chairman of the twelve-member family board. Jon Baumhauer (69), previously Chairman of the Family Board and Chairman of the Executive Board of E. Merck KG, has retired from his offices for age reasons. Stangenberg-Haverkamp, who has been a member of the Board of Partners since 1984, has been elected Vice Chairman.

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact E. Merck KG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at